Darin Lippoldt Insider Trades & Stock Holdings

Chief Legal Officer · Neurocrine Biosciences, Inc. · Latest filing Jun 29, 2026

Darin Lippoldt, Chief Legal Officer at Neurocrine Biosciences, Inc. has 8 Form 4 trades on file since Jun 26, 2026. Open-market activity: 0 purchases ($0) and 2 sales ($3.34M), net -$3.34M. Latest filing: disposed of 9.80K shares of $NBIX on Jun 29, 2026 at $170.16.

Trades on file

8

Open-market bought

$0

Open-market sold

$3.34M

Net open-market

-$3.34M

Latest filing

Jun 29, 2026

All insider trades by Darin Lippoldt

Date	Ticker	Type	Shares	Price	Value	Owned after	ΔOwn	1W	1M	6M	Role	Filing	Story
Jun 29, 2026	$NBIX	Sell (Open-market sale) 10b5-1	9.80K	$170.16	$1.67M			+2.4%	+6.3%		Chief Legal Officer		Read
Jun 29, 2026	$NBIX	Sell (Open-market sale) 10b5-1	9.80K	$170.16	$1.67M			+2.4%	+6.3%		Chief Legal Officer		—
Jun 29, 2026	$NBIX	Buy (Option exercise)	9.80K	$81.49	$798.60K			+2.4%	+6.3%		Chief Legal Officer		Read
Jun 29, 2026	$NBIX	Buy (Option exercise)	9.80K	$81.49	$798.60K			+2.4%	+6.3%		Chief Legal Officer		Read
Jun 26, 2026	$NBIX	Sell (Option exercise)	200	$0	—			+3.3%	+4.7%		Chief Legal Officer		—
Jun 26, 2026	$NBIX	Sell (Option exercise)	200	$0	—			+3.3%	+4.7%		Chief Legal Officer		—
Jun 26, 2026	$NBIX	Buy (Option exercise)	200	$81.49	$16.30K			+3.3%	+4.7%		Chief Legal Officer		Read
Jun 26, 2026	$NBIX	Buy (Option exercise)	200	$81.49	$16.30K			+3.3%	+4.7%		Chief Legal Officer		Read

"Buy" means shares acquired on the Form 4 (including grants and option exercises); "Sell" means shares disposed. 1W / 1M / 6M = how the stock moved after the trade.

Stocks Darin Lippoldt traded

• $NBIX

Frequently asked questions

Has Darin Lippoldt been buying or selling stock?

Darin Lippoldt has 0 open-market purchases and 2 open-market sales on file, net -$3.34M. Grants, option exercises and tax withholding are listed separately because they are not open-market trades.

What was Darin Lippoldt's latest insider trade?

disposed of 9.80K shares of $NBIX on Jun 29, 2026 at $170.16.

Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.